Fibrosis Progression in Hepatitis C Positive Liver Recipients After Sustained Virologic Response to Antiviral Combination Therapy (Interferon???Ribavirin Therapy)-Reference-Cited by-同舟云学术

Fibrosis Progression in Hepatitis C Positive Liver Recipients After Sustained Virologic Response to Antiviral Combination Therapy (Interferon???Ribavirin Therapy)

Published:2007-02 Issue:3 Volume:83 Page:351-353
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Bahra Marcus,Neumann Ulf P.,Jacob Dietmar,Langrehr Jan M.,Berg Thomas,Neuhaus Ruth,Neuhaus Peter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference14 articles.

1. Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

2. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C

3. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation. A long-term follow-up.

4. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lebertransplantation;Pathologie;2020

2. Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation;Journal of Gastrointestinal Surgery;2019-02-04

3. Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct-acting antivirals: Therapy of HCV-recurrence;Transplant Infectious Disease;2018-11-27

4. The impact of directly acting antivirals on the enzymatic liver function of liver transplant recipients with recurrent hepatitis C;Transplant Infectious Disease;2016-11-01

5. Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus;World Journal of Gastroenterology;2016